Tyra Biosciences, Inc. (TYRA)
Data as of , from SEC Form 4 filings.
See up to 3 months of TYRA. The 7-day demo opens the 1M and 3M ranges and puts TYRA on your watchlist.
Start 7-day demoLatest TYRA insider trades
- RA CAPITAL MANAGEMENT, L.P. - DirectorOpen-market purchase$199.99M
Rehan Verjee - DirectorOpen-market purchase$20K
About Tyra Biosciences, Inc. (TYRA)
The SEC lists Tyra Biosciences, Inc. under CIK 0001863127, in pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
TYRA Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 2 | 9,079,501 | $200.01M |
| Grant or award | 3 | 4,740 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
TYRA insider transactions (Form 4)
4549 Form 4 filings on record, the earliest from Oct 2, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Daniel Bensen - Officer | Grant or award | Stock Option (Right to Buy) | 170,000 | $0.00 | - | |
| Douglas J. Warner - Officer | Grant or award | Stock Option (Right to Buy) | 200,000 | $0.00 | - | |
| Todd Harris - Officer | Grant or award | Stock Option (Right to Buy) | 570,000 | $0.00 | - | |
| Alan Fuhrman - Officer | Grant or award | Stock Option (Right to Buy) | 170,000 | $0.00 | - | |
| Gilla Kaplan | Open-market sale | Common Stock | 10 | $10.35 | $104 | |
| Gilla Kaplan | Open-market sale | Common Stock | 9,568 | $9.78 | $94K | |
| Gilla Kaplan | Open-market sale | Common Stock | 30,000 | $10.31 | $309K | |
| Gilla Kaplan | Open-market sale | Common Stock | 15,000 | $10.31 | $155K | |
| Gilla Kaplan | Open-market sale | Common Stock | 6,814 | $10.38 | $71K | |
| Gilla Kaplan | Grant or award | Stock Option (Right to Buy) | 22,200 | $0.00 | - | |
| Robert J. More | Grant or award | Stock Option (Right to Buy) | 22,200 | $0.00 | - | |
| Nina S. Kjellson | Open-market sale | Common Stock | 4,706 | $16.84 | $79K | |
| Nina S. Kjellson | Open-market sale | Common Stock | 566 | $16.84 | $10K | |
| RA CAPITAL MANAGEMENT, L.P. | Open-market purchase | Common Stock | 1,220,681 | $16.25 | $19.84M | |
| Nina S. Kjellson | Open-market sale | Common Stock | 46,856 | $17.18 | $805K | |
| Nina S. Kjellson | Open-market sale | Common Stock | 5,635 | $17.18 | $97K | |
| Nina S. Kjellson | Open-market sale | Common Stock | 19,720 | $17.32 | $342K | |
| Nina S. Kjellson | Open-market sale | Common Stock | 2,371 | $17.32 | $41K | |
| Nina S. Kjellson | Open-market sale | Common Stock | 960 | $17.01 | $16K | |
| Nina S. Kjellson | Open-market sale | Common Stock | 116 | $17.01 | $2K | |
| Nina S. Kjellson | Open-market sale | Common Stock | 9,367 | $16.77 | $157K | |
| Nina S. Kjellson | Open-market sale | Common Stock | 1,126 | $16.77 | $19K | |
| Alan Fuhrman - Officer | Open-market purchase | Common Stock | 9,500 | $16.00 | $152K | |
| Nina S. Kjellson | Open-market sale | Common Stock | 9,889 | $16.17 | $160K | |
| Nina S. Kjellson | Open-market sale | Common Stock | 1,189 | $16.17 | $19K | |
| Nina S. Kjellson | Open-market sale | Common Stock | 89,390 | $16.46 | $1.47M | |
| Nina S. Kjellson | Open-market sale | Common Stock | 10,750 | $16.46 | $177K | |
| Nina S. Kjellson | Open-market sale | Common Stock | 23,938 | $16.54 | $396K | |
| Nina S. Kjellson | Open-market sale | Commmon Stock | 604 | $17.16 | $10K | |
| Nina S. Kjellson | Open-market sale | Common Stock | 2,878 | $16.54 | $48K | |
| Nina S. Kjellson | Open-market sale | Common Stock | 73 | $17.16 | $1K | |
| Boxer Capital Management, LLC | Derivative | Common Stock | 2,000,000 | - | - | |
| Boxer Capital Management, LLC | Grant or award | Pre-Funded Warrant (right to purchase) | 2,000,000 | - | - | |
| Todd Harris - Officer | Open-market sale | Common Stock | 43,636 | $27.01 | $1.18M | |
| Todd Harris - Officer | Open-market sale | Common Stock | 5,896 | $27.32 | $161K | |
| Todd Harris - Officer | Open-market sale | Common Stock | 13,188 | $28.16 | $371K | |
| RA CAPITAL MANAGEMENT, L.P. | Other | Common Stock | 1,000,000 | - | - | |
| RA CAPITAL MANAGEMENT, L.P. | Other | Pre-Funded Warrants (Right to Buy) | 2,358,457 | - | - | |
| Todd Harris - Officer | Open-market sale | Common Stock | 10,035 | $24.31 | $244K | |
| Todd Harris - Officer | Open-market sale | Common Stock | 4,900 | $25.22 | $124K | |
| Todd Harris - Officer | Open-market sale | Common Stock | 24,475 | $26.23 | $642K | |
| Todd Harris - Officer | Open-market sale | Common Stock | 3,922 | $26.98 | $106K | |
| Todd Harris - Officer | Open-market sale | Common Stock | 15,194 | $25.84 | $393K | |
| Todd Harris - Officer | Open-market sale | Common Stock | 200 | $26.37 | $5K | |
| Todd Harris - Officer | Open-market sale | Common Stock | 500 | $24.00 | $12K |
Recent TYRA Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - |
TYRA insider trading FAQ
What is the latest insider trade for TYRA?
Tyra Biosciences, Inc. (TYRA) had 5 insider filings in the last 90 days, with the most recent on 2026-09-17. The full record for TYRA runs to 49 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying TYRA stock?
2 insider purchases of TYRA were filed in the last 90 days, totaling $200.01M.
How many insiders are selling TYRA stock?
No insider sales of TYRA were filed in the last 90 days. 47 sales are on record for this company.
Where can I see TYRA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects TYRA Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Todd Harris view on EDGAR
- - Yuliya Rueb view on EDGAR
- - Alan Fuhrman view on EDGAR
- - RA CAPITAL MANAGEMENT, L.P. view on EDGAR
- - Rehan Verjee view on EDGAR
- - RA CAPITAL MANAGEMENT, L.P. view on EDGAR
- - Rehan Verjee view on EDGAR
- - Susan Moran view on EDGAR
- - Jake Simson view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where TYRA's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow TYRA with a 7-day demo
- TYRA on your watchlist
- Every TYRA Form 4 filing on record
- Up to 3 months of TYRA price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
